Skip to main content
Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2018 2017 2016 2015 2014 2013
Trillium Therapeutics Reports Third Quarter 2018 Financial and Operating Results
November 14, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics to Provide Update on TTI-621 Clinical Programs at Two Scientific Conferences
September 28, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics to Present at Upcoming Investor Conferences
September 27, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Announces Data Presentations at Upcoming Scientific Meetings
September 12, 2018
Download PDF format download (opens in new window)
Trillium to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 30, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Reports Second Quarter 2018 Financial and Operating Results
August 8, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement
June 19, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Completes Amendment to SIRPaFc License Agreement
June 15, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Doses First Patient With TTI-622, Its Second Immune Checkpoint Inhibitor Targeting CD47
June 14, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer
June 7, 2018
Download PDF format download (opens in new window)
Trillium Announces Voting Results From the Annual and Special Meeting of Shareholders
June 5, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results
May 11, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Reports TTI-622 Preclinical Data at the 2018 AACR Annual Meeting
April 18, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics To Report Preclinical Data On TTI-621 And TTI-622 At The AACR Annual Meeting 2018
April 12, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Provides Update on its TTI-621 and TTI-622 Clinical Programs
April 10, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics' TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma
March 20, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Reports Annual 2017 Financial And Operating Results
March 9, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics to Present at Investor and Scientific Conferences in the First Quarter
February 9, 2018
Download PDF format download (opens in new window)
Trillium Therapeutics Enhances Senior Management Team to Support Further Clinical Development of TTI-621
January 17, 2018
Download PDF format download (opens in new window)